GlassScriptPhysician profile
Julia Retzky
NPI 1033653084
$25,234.48
in general payments reported to CMS, 2019-2025
9 companies · $25K in 2025
The $25K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $337 · 2022: $70.33 · 2023: $209 · 2024: $19.26 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $23K · Travel and Lodging: $886 · Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $23,214.33 |
| Travel and Lodging | $886.47 |
| Food and Beverage | $726.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $17,142.90 | 2025 | |
| Smith+Nephew, INC. | $6,071.43 | 2025 | |
| Linvatec Corporation | $1,012.26 | 2025 | Biobrace 23mm |
| Stryker Corporation | $372.26 | 2021-2024 | Insignia, Triathlon, Accolade |
| Osteoremedies, LLC | $194.30 | 2025 | Biobrush, Osteoboost Select 5cc, Biowash Surgical Irrigation |
| Exactech, INC. | $181.54 | 2023 | |
| Overture Orthopaedics | $178.58 | 2025 | Overtureti |
| Depuy Synthes Sales INC. | $67.69 | 2021 | |
| Kci USA, INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Retzky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.